HDAC Inhibitors in Friedreich's Ataxia (8 of 13)
1,016 views · Published 11 December 2012 · 40:18 · Indexed 10 November 2026
Channel: The Children's Hospital of Philadelphia · 2012 · Science & Technology
James Rusche, PhD, Sr. Vice President, Research and Development, Repligen Corporation, discusses the work his company has done to identify development candidate for Friedreich's Ataxia.
More from this channel
-
2:17
Importance of a Specialized Center for the Diagnosis and Treatment of Teratomas (10 of 10)
-
1:35
Short- and Long-term Outcomes for Children with Teratomas (9 of 10)
-
2:35
Before the Vaccine - Vaccines and Your Baby - The Children's Hospital of Philadelphia (2 of 14)
-
0:46
Can My Baby Get 4 or 5 Vaccines at a Time? - The Children's Hospital of Philadelphia (5 of 10)
-
0:34
Public Service Announcement - Youth Heart Watch - The Children's Hospital of Philadelphia (3 of 3)
-
6:36
Every Second Counts - Youth Heart Watch - The Children's Hospital of Philadelphia (2 of 3)
-
1:58
Why Choose a Specialized Center for Delivery of Babies with Large CCAM (8 of 10)
-
4:21
Evaluation - Scoliosis and Thoracic Insufficiency Syndrome (3 of 8)